2-165294011-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_001040142.2(SCN2A):c.-51-1762A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00031 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00047 ( 0 hom. )
Consequence
SCN2A
NM_001040142.2 intron
NM_001040142.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.292
Genes affected
SCN2A (HGNC:10588): (sodium voltage-gated channel alpha subunit 2) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with four repeat domains, each of which is composed of six membrane-spanning segments, and one or more regulatory beta subunits. Voltage-gated sodium channels function in the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. Allelic variants of this gene are associated with seizure disorders and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000306 (4/13082) while in subpopulation NFE AF= 0.000846 (4/4726). AF 95% confidence interval is 0.000289. There are 0 homozygotes in gnomad4. There are 1 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAdExome4 at 93 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN2A | NM_001040142.2 | c.-51-1762A>T | intron_variant | ENST00000375437.7 | NP_001035232.1 | |||
SCN2A | NM_001371246.1 | c.-51-1762A>T | intron_variant | ENST00000631182.3 | NP_001358175.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN2A | ENST00000375437.7 | c.-51-1762A>T | intron_variant | 5 | NM_001040142.2 | ENSP00000364586.2 | ||||
SCN2A | ENST00000631182.3 | c.-51-1762A>T | intron_variant | 5 | NM_001371246.1 | ENSP00000486885.1 | ||||
SCN2A | ENST00000424833.5 | c.-51-1762A>T | intron_variant | 1 | ENSP00000406454.2 | |||||
SCN2A | ENST00000283256.10 | c.-176A>T | upstream_gene_variant | 1 | ENSP00000283256.6 |
Frequencies
GnomAD3 genomes AF: 0.000383 AC: 5AN: 13060Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
5
AN:
13060
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000473 AC: 93AN: 196466Hom.: 0 Cov.: 0 AF XY: 0.000342 AC XY: 31AN XY: 90522
GnomAD4 exome
AF:
AC:
93
AN:
196466
Hom.:
Cov.:
0
AF XY:
AC XY:
31
AN XY:
90522
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000306 AC: 4AN: 13082Hom.: 0 Cov.: 0 AF XY: 0.000156 AC XY: 1AN XY: 6430
GnomAD4 genome
AF:
AC:
4
AN:
13082
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
6430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Seizures, benign familial infantile, 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at